CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.
Industry, Sector and Symbol:
- Industry: Health Care Equipment & Supplies
- Sub-Industry: Health Care Equipment
- Symbol: NYSE:CFN
- CUSIP: 14170T10
- Web: N/A
- 50 Day Moving Avg: $60.00
- 200 Day Moving Avg: $57.00
- 52 Week Range: $38.00 - $60.00
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 20.00
- P/E Growth: 0
- Average Volume: 2.42 million shs.
Frequently Asked Questions for CareFusion (NYSE:CFN)
What is CareFusion's stock symbol?
CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."
How were CareFusion's earnings last quarter?
CareFusion Co. (NYSE:CFN) posted its quarterly earnings data on Thursday, February, 5th. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.79 by $0.20. The company earned $1.07 billion during the quarter, compared to analysts' expectations of $1.01 billion. The company's revenue for the quarter was up 15.9% on a year-over-year basis. During the same quarter last year, the company earned $0.54 earnings per share. View CareFusion's Earnings History.
Who are some of CareFusion's key competitors?
Some companies that are related to CareFusion include Merck KGaA (MKGAY), Hospira (HSP), Omnicare (OCR), Health Net (HNT), WuXi PharmaTech (Cayman) (WX), Hanger (HGR), SIGA Technologies (SIGA), Nobilis Health Corp (HLTH), Verastem (VSTM), Palatin Technologies (PTN), KaloBios Pharmaceuticals (KBIO), AdCare Health Systems (ADK), Capricor Therapeutics (CAPR), 3SBio (SSRX), Alexza Pharmaceuticals (ALXA), Allergan plc (WPI), Allergan plc (ACT) and Allos Therapeutics (ALTH).
How do I buy CareFusion stock?
Shares of CareFusion can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CareFusion's stock price today?
MarketBeat Community Rating for CareFusion (NYSE CFN)MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of CareFusion stock can currently be purchased for approximately $60.00.
Consensus Ratings for CareFusion (NYSE:CFN) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for CareFusion (NYSE:CFN)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for CareFusion (NYSE:CFN)Earnings History by Quarter for CareFusion (NYSE CFN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/5/2015||Q215||$0.79||$0.99||$1.01 billion||$1.07 billion||View||N/A|
|11/6/2014||Q115||$0.49||$0.50||$920.50 million||$922.00 million||View||N/A|
|8/7/2014||Q414||$0.72||$0.79||$1.04 billion||$1.12 billion||View||Listen|
|5/5/2014||Q314||$0.62||$0.60||$986.67 million||$968.00 million||View||Listen|
|2/3/2014||Q214||$0.54||$0.54||$911.13 million||$922.00 million||View||Listen|
|8/8/2013||Q4 2013||$0.56||$0.55||$918.25 million||$903.00 million||View||Listen|
|5/9/2013||Q3 2013||$0.53||$0.59||$909.16 million||$901.00 million||View||Listen|
Earnings Estimates for CareFusion (NYSE:CFN)
Current Year EPS Consensus Estimate: $3 EPS
Next Year EPS Consensus Estimate: $3 EPS
Dividend History for CareFusion (NYSE:CFN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for CareFusion (NYSE:CFN)Insider Trades by Quarter for CareFusion (NYSE:CFN)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|2/6/2015||Jonathan Wygant||CAO||Sell||1,700||$59.79||$101,643.00|| |
|2/6/2015||Philip L Francis||Director||Sell||40,980||$59.89||$2,454,292.20|| |
|12/15/2014||Thomas J Leonard||Insider||Sell||25,000||$58.87||$1,471,750.00|| |
|12/4/2014||Donald Abbey||EVP||Sell||1,000||$59.35||$59,350.00|| |
|11/12/2014||J Michael Losh||Director||Sell||12,630||$57.32||$723,951.60|| |
|10/6/2014||James F Hinrichs||CFO||Sell||20,000||$56.91||$1,138,200.00|| |
|10/6/2014||Thomas J Leonard||Insider||Sell||8,400||$57.16||$480,144.00|| |
|10/1/2014||James F Hinrichs||CFO||Sell||20,000||$45.07||$901,400.00|| |
|9/19/2014||Thomas J Leonard||Insider||Sell||16,600||$47.01||$780,366.00|| |
|9/15/2014||Thomas J Leonard||Insider||Sell||25,000||$46.17||$1,154,250.00|| |
|7/7/2014||Thomas J Leonard||Insider||Sell||1,250||$45.47||$56,837.50|| |
|7/1/2014||Thomas J Leonard||Insider||Sell||19,721||$45.00||$887,445.00|| |
|6/6/2014||James F Hinrichs||CFO||Sell||21,506||$44.07||$947,769.42|| |
|6/2/2014||Thomas J Leonard||Insider||Sell||1,250||$42.81||$53,512.50|| |
|5/29/2014||Fortune Gordon La||EVP||Sell||2,158||$42.61||$91,952.38|| |
|5/20/2014||Kieran Gallahue||CEO||Sell||100,000||$42.98||$4,298,000.00|| |
|5/19/2014||Fortune Gordon La||EVP||Sell||38,738||$42.70||$1,654,112.60|| |
|5/19/2014||Thomas Leonard||Insider||Sell||30,000||$42.89||$1,286,700.00|| |
|5/5/2014||Thomas Leonard||Insider||Sell||1,250||$39.06||$48,825.00|| |
|4/7/2014||Thomas Leonard||Insider||Sell||1,250||$40.05||$50,062.50|| |
|4/4/2014||Donald Abbey||EVP||Sell||10,076||$41.79||$421,076.04|| |
|3/3/2014||Thomas Leonard||Insider||Sell||1,250||$40.26||$50,325.00|| |
|2/5/2014||Philip Francis||Director||Buy||6,500||$38.61||$250,965.00|| |
|2/5/2014||Thomas Leonard||Insider||Sell||21,496||$38.24||$822,007.04|| |
|1/9/2014||Kieran Gallahue||CEO||Sell||25,000||$41.05||$1,026,250.00|| |
|1/6/2014||Thomas Leonard||Insider||Sell||1,250||$39.48||$49,350.00|| |
|12/2/2013||James Hinrichs||CFO||Sell||28,078||$40.13||$1,126,770.14|| |
|12/2/2013||Kieran Gallahue||CEO||Sell||25,000||$40.09||$1,002,250.00|| |
|12/2/2013||Thomas Leonard||Insider||Sell||1,250||$39.99||$49,987.50|| |
|11/4/2013||Thomas J Leonard||Insider||Sell||1,250||$39.06||$48,825.00|| |
|10/1/2013||Thomas J Leonard||Insider||Sell||1,250||$36.99||$46,237.50|| |
|9/9/2013||Fortune Gordon La||EVP||Sell||33,960||$36.55||$1,241,238.00|| |
|9/3/2013||Thomas Leonard||Insider||Sell||1,250||$35.70||$44,625.00|| |
|8/26/2013||J Michael Losh||Director||Sell||53,311||$35.67||$1,901,603.37|| |
Headline Trends for CareFusion (NYSE:CFN)
Latest Headlines for CareFusion (NYSE:CFN)
CareFusion (CFN) Chart for Tuesday, May, 30, 2017